Cell and gene therapy venture capital and public funding deal value

STO-REC-STAT01M2KJT3 Research
3.4 billionUSD

Global · 2023

Cell and gene therapy venture capital and public funding deal value worldwide stood at 3.4 billion USD in 2023 (IQVIA).

Original source
Publisher
IQVIA
Authority tier
T3 Research
Locator
Cell and gene therapy venture capital and public funding deal value in U.S.$$Mn and number of deals by type, 2014-2023
Retrieved
15 Sep 2026
Status
Verified

What the source says

Following historic funding levels in 2021 and a retraction in 2022, nearly 100 deals and $3.4Bn of deal value occurred in 2023.

Verbatim extraction verified: The figure 3.4 billion USD is directly attested in the quoted passage (Cell and gene therapy venture capital and public funding deal value in U.S.$$Mn and number of deals by type, 2014-2023).

The figure above was extracted from this passage. If it does not match, the extraction is wrong and we want to know.

Cite this figure

Published under CC BY 4.0. Attribute the original publisher; the citations below do that for you and link to this permanent record.

APA
IQVIA Institute. (2023). Strengthening Pathways for Cell and Gene Therapies: Current State and Future Scenarios. Retrieved September 15, 2026, from https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/strengthening-pathways-for-cell-and-gene-therapies. Via StatOrigin, https://statorigin.org/stat/stat_01M2KJ7XCF5037JCNPDKKT7NNH
MLA
IQVIA Institute. "Strengthening Pathways for Cell and Gene Therapies: Current State and Future Scenarios." 2023, https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/strengthening-pathways-for-cell-and-gene-therapies. Accessed 15 Sept. 2026 via StatOrigin, https://statorigin.org/stat/stat_01M2KJ7XCF5037JCNPDKKT7NNH.
Chicago
IQVIA Institute. "Strengthening Pathways for Cell and Gene Therapies: Current State and Future Scenarios." 2023. https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/strengthening-pathways-for-cell-and-gene-therapies. Accessed September 15, 2026. Cited from StatOrigin, https://statorigin.org/stat/stat_01M2KJ7XCF5037JCNPDKKT7NNH.
BibTeX
@misc{iqvia2023cellkt7nnh, author = {{IQVIA Institute}}, title = {Strengthening Pathways for Cell and Gene Therapies: Current State and Future Scenarios}, year = {2023}, howpublished = {StatOrigin, https://statorigin.org}, url = {https://statorigin.org/stat/stat_01M2KJ7XCF5037JCNPDKKT7NNH}, note = {Original source: https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/strengthening-pathways-for-cell-and-gene-therapies. Accessed September 15, 2026.} }

Provenance and verification

Everything needed to check this number yourself, without taking our word for it.

Chain of Custody · Verification Audit
Record: STO-REC-STAT01M2KJ T3 Research

Primary Source

Publisher
IQVIA Institute · homepage ↗
Authority tier
Tier 3 · Industry & Research
Report
Strengthening Pathways for Cell and Gene Therapies: Current State and Future Scenarios
Type
Press release
Published
Locator
Cell and gene therapy venture capital and public funding deal value in U.S.$$Mn and number of deals by type, 2014-2023
Retrieved
15 September 2026
Link status
Reachable (HTTP 200)
Report licence
See source

Verification & Integrity

Audit status
Verified
Review protocol
Editorial review
Checked on
15 September 2026
Last revision
15 September 2026
Archival URI
/stat/stat_01M2KJ7XCF5037JCNPDKKT7NNH